More than 1.3 million people in the United States live with cutaneous melanoma, and the overall 5-year survival is 93.7%.
The learning curve for dermoscopy is steep, he added, and whether the technique should be considered a first-line tool or as a supplement to other...
Integrating palliative care into routine cancer care need not always require a specialty palliative care nurse.
Immunotherapy and targeted therapy appear to be paying dividends, new study finds.
"High numbers of nevi and high genetic predisposition were more strongly associated with second [rather] than first primary melanomas."
A qualitative study in California reveals challenges and attitudes that could be addressed with new melanoma outreach and prevention strategies....
Phase 2 trial achieves some success, and responders had infiltrate of plasmacytoid dendritic cells.
While the use of immunotherapies over the past decade has improved the prognosis for patients with advanced melanoma, these drugs come with a...
“This analysis provides additional empirical evidence on the magnitude of risk to patients with cancer whose immune systems are often weakened...
It’s possible that low uptake could stem from clinicians’ doubts about switching to an extended-interval dose, given that the FDA’s approval was...